Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China.

Tao WangRuidi TangHonglian RuanRuchong ChenZili ZhangLing SangXi SuShuting YiZhengyi NiYu HuLei LiuHong ShanChunliang LeiYixiang PengChunli LiuJing LiCheng HongNuofu ZhangNanshan ZhongShiyue Linull null

Published in: The clinical respiratory journal (2021)

Among COVID-19 patients with pre-existing hypertension, elevated hs-cTn and IL-6 could help clinicians to identify patients with fatal outcomes at an early stage, blood pressure control is associated with better clinical outcomes, and RAAS suppressors do not increase mortality and may decrease the need for ICU admission.

Keyphrases

blood pressure
early stage
sars cov
hypertensive patients
heart rate
emergency department
intensive care unit
palliative care
risk factors
cardiovascular disease
coronary artery disease
squamous cell carcinoma
radiation therapy
skeletal muscle
extracorporeal membrane oxygenation
arterial hypertension